Statins Therapy may Change a Course of Lung Fibrosis and Pulmonary Hypertension: A New Indication for Therapy or Just “Statinomania”?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6387|5|1|21-27

ISSN： 1573-398X

Source： Current Respiratory Medicine Reviews, Vol.5, Iss.1, 2009-02, pp. : 21-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Idiopathic Pulmonary Fibrosis: New Concepts in Pathogenesis and Implications for Drug Therapy

By Horowitz Jeffrey C.   Thannickal Victor J.  

Treatments in Respiratory Medicine, Vol. 5, Iss. 5, 2006-01 ,pp. : 325-342

Adis International

Access to resources Recommend Favorite

Recent Advances in Pulmonary Hypertension Therapy

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 28-36

Bentham Science Publishers

Access to resources Recommend Favorite

Bosentan therapy for pulmonary arterial hypertension

By Provencher Steeve   Jais Xavier   Sitbon Olivier  

Future Cardiology, Vol. 1, Iss. 3, 2005-05 ,pp. : 299-309

Future Medicine

Access to resources Recommend Favorite

Pulmonary Hypertension: Role of Combination Therapy

By  

Current Vascular Pharmacology, Vol. 9, Iss. 4, 2011-07 ,pp. : 457-464

Bentham Science Publishers

Access to resources Recommend Favorite

Pathophysiological Basis for Anticoagulant and Antithrombotic Therapy in Pulmonary Hypertension

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 4, Iss. 1, 2006-01 ,pp. : 53-59

Bentham Science Publishers

Access to resources Recommend Favorite